LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | PI103 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1293 | 3228 | 0.4006 | 0.1582 |
Hs 578T | PLX-4720 | 10.0 | uM | LJP5 | 72 | hr | 929 | 2889 | 3228 | 0.8952 | 0.8528 |
Hs 578T | QL-X-138 | 10.0 | uM | LJP6 | 72 | hr | 929 | 980 | 3228 | 0.3036 | 0.0221 |
Hs 578T | QL-XII-47 | 10.0 | uM | LJP6 | 72 | hr | 929 | 822 | 3228 | 0.2546 | -0.0467 |
Hs 578T | Radicicol | 10.0 | uM | LJP5 | 72 | hr | 929 | 1307 | 3228 | 0.4050 | 0.1645 |
Hs 578T | Radicicol | 10.0 | uM | LJP6 | 72 | hr | 929 | 1261 | 3228 | 0.3907 | 0.1445 |
Hs 578T | Seliciclib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2538 | 3228 | 0.7864 | 0.7001 |
Hs 578T | Ruxolitinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2421 | 3228 | 0.7502 | 0.6492 |
Hs 578T | XL147 | 10.0 | uM | LJP5 | 72 | hr | 929 | 2805 | 3228 | 0.8689 | 0.8160 |
Hs 578T | Saracatinib | 10.0 | uM | LJP6 | 72 | hr | 929 | 1622 | 3228 | 0.5026 | 0.3015 |
Hs 578T | Selumetinib | 10.0 | uM | LJP6 | 72 | hr | 929 | 1501 | 3228 | 0.4650 | 0.2487 |
Hs 578T | Sirolimus | 10.0 | uM | LJP6 | 72 | hr | 929 | 2276 | 3228 | 0.7052 | 0.5860 |
Hs 578T | Sorafenib | 10.0 | uM | LJP6 | 72 | hr | 929 | 3036 | 3228 | 0.9406 | 0.9166 |
Hs 578T | SU11274 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1371 | 3228 | 0.4247 | 0.1922 |
Hs 578T | Fedratinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 921 | 3228 | 0.2853 | -0.0036 |
Hs 578T | TGX221 | 10.0 | uM | LJP5 | 72 | hr | 929 | 2401 | 3228 | 0.7439 | 0.6404 |
Hs 578T | Torin1 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1031 | 3228 | 0.3195 | 0.0444 |
Hs 578T | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 929 | 949 | 3228 | 0.2942 | 0.0089 |
Hs 578T | Tozasertib | 10.0 | uM | LJP5 | 72 | hr | 929 | 1127 | 3228 | 0.3493 | 0.0863 |
Hs 578T | Trametinib | 10.0 | uM | LJP5 | 72 | hr | 929 | 1497 | 3228 | 0.4640 | 0.2473 |
Hs 578T | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1000 | 3228 | 0.3099 | 0.0309 |
Hs 578T | Vemurafenib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2051 | 3228 | 0.6355 | 0.4881 |
Hs 578T | Withaferin A | 10.0 | uM | LJP5 | 72 | hr | 929 | 558 | 3228 | 0.1729 | -0.1615 |
Hs 578T | Withaferin A | 10.0 | uM | LJP6 | 72 | hr | 929 | 411 | 3228 | 0.1274 | -0.2253 |
Hs 578T | WYE-125132 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1265 | 3228 | 0.3920 | 0.1462 |